INTRODUCTION
The most common primary bone cancer in children and teenagers is osteosarcoma (Chen et al., 2018a; Suárez et al., 2017). The main difficulty in treating this cancer is that it begins to develop in the skeletal system and it can develop metastasis and spread to other organs of the body, making its timely diagnosis complex. The standard osteosarcoma treatment includes local surgical control, with radical surgery or limb preservation, and the administration of polychemotherapy (methotrexate, doxorubicin, cisplatin, and ifosfamide) (Suárez et al., 2017). The prognosis of patients with osteosarcoma can be improved with the combination of surgery and chemotherapy. However, a considerable number of patients have developed resistance to chemotherapy (Chen et al., 2018b). In addition, some chemotherapeutic agents are not selective since they also attack normal cells and generate toxic side effects (Ferrari and Palmerini, 2007; Zhao et al., 2015b). To overcome this situation, antitumor agents or chemical products with increased efficiency and reduced toxicity are being developed (Zhao et al., 2015b).
For the treatment of cancer, Chinese medicines have been used as either food ingredients or supplements. Generally, cancer patients use herbal medicines with conventional medical treatment to improve the desired results (Ko et al., 2017). Among these Chinese herbal medicines, mushrooms represent a source of compounds with antioxidant, immunomodulating, anti-inflammatory, antimicrobial, and anticancer properties (Ricciardi et al., 2017). Mushrooms have been consumed for many years because they have a large number of bioactive compounds, including polysaccharides, proteins, and lipids (Wasser, 2011). Specifically, the anticancer potential to treat various types of cancer by some species of the genus Trametes, such as Trametes versicolor (synonym Coriolus versicolor), Trametes gibbosa, Trametes hirsuta, Trametes lactinea, and Trametes robiniophila, has been reported. In general, this anticancer activity has been attributed to chemical compounds such as polysaccharides (He et al., 2018; Ricciardi et al., 2017; Rosendahl et al., 2012; Scarpari et al., 2017; Wang et al., 2017a, 2017b; Zhao et al., 2015a, 2015b) and tetralin lignans (Puri et al., 2006). Mushroom polysaccharides are significant compounds with anticancer, anti-oxidative, antidiabetic, antimicrobial, anti-inflammatory, and immunomodulatory activity. β-glucan is the main polysaccharide found in mushrooms and it makes up about half the mass of its cell wall (Amirullah et al., 2018).
T. versicolor essentially contains polysaccharide-K or Krestin (PSK) and polysaccharide peptide (PSP). In PSK, roughly 62% of the molecule is polysaccharide and 38% is protein and PSP is a protein-bound polysaccharide (Fritz et al., 2015). PSK has shown anticancer activity in breast, colorectal, and gastrointestinal cancers (Blagodatski et al., 2018; Kiyama, 2017). T. robiniophila has demonstrated an antiproliferative effect on the diversity of tumor cells via inducing apoptosis (Ren et al., 2009; Zhao et al., 2015a). Proteoglycans have been recognized as the principal components answerable for the anticancer activity of T. robiniophila (Li et al., 2015; Sun et al., 2013; Zhao et al., 2015b).
In this regard, the aim of this systematic review is to analyze the information from reports which demonstrate the anticancer activity of the bioactive compounds isolated from several species of the genus Trametes on human osteosarcoma.
MATERIALS AND METHODS
Search terms
The present systematic review involved research articles from the Science Direct, Pubmed Central and Embase databases from 2000 to May 2019. The search terms were “T. versicolor”, “osteosarcoma OR bone cancer OR anticancer”, and “bioactive compounds OR metabolites” and the keywords “in vivo OR in vitro” were used as a search strategy. The articles were selected first by the title, then by the summary, and finally by reading the full text. Two relevant articles were found through manual searches in the reference lists.
Inclusion and exclusion criteria
Finally, the articles were chosen by taking into account some inclusion and exclusion criteria (see Table 1).
Quality evaluation
The quality of the articles included in this review was systematically evaluated. The quality score was assigned considering the following five items: characterization of extracts or compounds of interest (2 points), anticancer tests in vitro, ex vivo, and in vivo (2 points for each test), and the use of controls in anticancer tests (2 points) for a maximum score of 10 points.
Quality evaluation of the parameters
Characterization of extracts or compounds of interest
- If the extract or the compound of interest is not characterized: 0 points.
- If the extract or the compound of interest is characterized by generic tests (presence of carbohydrates, total phenolic content, etc.): 1 point.
- If the extract or the compound of interest is characterized by specific tests (FTIR (Fourier-transform infrared spectroscopy), NMR (Nuclear Magnetic Resonance), etc.): 2 points.
Anticancer tests in vitro
- If in vitro anticancer tests are not performed: 0 points.
- If in vitro anticancer tests are performed: 2 points.
Anticancer tests ex vivo
- If ex vivo anticancer tests are not performed: 0 points.
- If ex vivo anticancer tests are carried out: 2 points.
Anticancer tests in vivo
- If in vivo anticancer tests are not performed: 0 points.
- If in vivo anticancer tests are performed: 2 points.
Use of controls in anticancer tests
- If controls are not used in anticancer tests: 0 points.
- If at least one control is used in anticancer tests (positive control or negative control): 1 point.
- If two controls are used in anticancer tests (positive control and negative control): 2 points.
Quality ranges
The articles with 8–10, 4–7, and 0–3 points were recognized as high, moderate, and low quality, respectively.
Data extraction
The information extracted from each study included author name, publication year, country, main objective, and main findings of each research. In order to guarantee the success of the revision process, the data analysis and assessment were carried out by three independent reviewers, who assessed the reproducibility and the probability of bias in each stage of the review.
RESULTS
Selection of studies
The initial search through databases identified 343 articles. After removing duplicates, the remaining 165 articles were reviewed based on the title and the abstract by reviewers. A total of 21 articles were reviewed based on full-text availability. Finally, the 15 studies included in our systematic review met the inclusion criteria. Figure 1 shows the flow diagram of the search results.
.png) | Table 1. Inclusion and exclusion criteria. [Click here to view] |
.png) | Figure 1. Flow diagram of study selection process. [Click here to view] |
Characteristics of the studies
Among the 15 research articles included, 2 studies evaluated the anticancer activity of ethanol extracts of the fruiting body (Janjušević et al., 2018) and basidiocarp and mycelium (Knežević et al., 2018); 4 studies evaluated the activity of a polysaccharide-rich aqueous extract of the fruiting body (Roca-Lema et al., 2019), an aqueous extract of the fruiting body (Ko et al., 2017; Luo et al., 2014), and mycelial biomass (Shnyreva et al., 2018). Moreover, 9 studies evaluated the activity of compounds such as polysaccharides (He et al., 2018; Zhao et al., 2015a, 2015b), PSK (Rosendahl et al., 2012), intracellular protein-polysaccharide (Wang et al., 2017a), extracellular polysaccharide (Wang et al., 2017b), Tramesan (Ricciardi et al., 2017; Scarpari et al., 2017), and tetralin lignans (Puri et al., 2006). Table 2 describes some features of each study, involving the year of publication, country, objective, extract or compound of interest, and the species of the mushrooms used.
Results of individual studies
All studies evaluate the cytotoxic effects of extracts or derivate compounds from different species of the genus Trametes in cell lines of various types of cancer. In some of these research articles, the mechanism underlying these effects was identified. Table 3 shows the anticancer assays and the principal findings of the individual reports.
Evaluation of the quality of the studies
Table 4 shows the quality assessment for each study based on the inclusion and exclusion criteria. The total average score was 4.8 ± 1.0. Hence, for articles where extracts were evaluated, an average score of 5.0 ± 1.2 was presented and for studies that evaluated specific compounds, such as polysaccharides, Tramesan, and tetralin lignans, an average quality score of 4.7 ± 1.0 was found. Although a high level of quality was not observed concerning the parameters defined by us, these results showed a satisfactory level of quality to validate the results and the conclusions.
.png) | Table 2. Main characteristics of the included studies. [Click here to view] |
.png) | Table 3. Anticancer tests and main findings of the individual studies. [Click here to view] |
.png) | Table 4. Quality assessment of studies. [Click here to view] |
DISCUSSION
Summary of results
This research intended to carry out a systematic review of the evidence on the anticancer activity of chemical compounds isolated from Trametes in human osteosarcoma. It should be noted that only two articles evaluated the in vitro (Zhao et al., 2015a) and in vivo (Zhao et al., 2015b) activity of polysaccharides isolated from T. robiniophila in human osteosarcoma. In these studies, the results suggested that polysaccharide-induced apoptosis occurs through a mitochondria-mediated intrinsic apoptotic pathway. However, in all the articles, the potential of the bioactive compounds present in mushrooms like Trametes to treat different types of cancer is confirmed; this potential could be attributed to the compounds like polysaccharides that presented a wide variety of mechanisms of anticancer activity. Among these mechanisms are the depolarization of the mitochondrial membrane, the cell cycle arrest, the nitric oxide pathway, and the immunomodulation (Khan et al., 2019).
The proteins implicated in proliferative pathways may induce or stop the apoptosis process in cells, thus allowing manipulation of the cell cycle. Apoptosis or programmed cell death occurs mostly through the caspase cascade (Pucci et al., 2003). On the other hand, depolarization of the mitochondrial membrane produces the release of cytochrome c into the cytoplasm. This release leads to the formation of an apoptosome complex, which produces the activation of caspases (caspase-9 and caspase-3), a group of cysteine proteases, which initiate apoptosis (Tian et al., 2016). Furthermore, an increase in the ratio of Bax/Bal2 (apoptosis inducer/apoptosis suppressor) is related to apoptosis induction (Khan et al., 2019).
Several polysaccharides boost macrophages to produce NO (Nitric oxide) by positively regulating the inducible NO synthase activity. NO can induce cytotoxicity by inhibiting essential enzymes, depleting antioxidant stores, inducing lipid peroxidation, and causing DNA damage. Also, most of these polysaccharides function independently to give anticancer activity, generating the release of cytokines and improving the expression of lymphocyte. It has also been indicated that the intensification in NO production generates the death of tumor cells via the caspase pathway. Furthermore, the polysaccharides have immunostimulant activity (Bao et al., 2013; Jiang et al., 2014; Khan et al., 2019)
Explanation of the results
Complete research articles incorporated in this systematic review indicated that extracts, as well as isolated compounds from different species of Trametes, displayed cytotoxic potential in various types of cancer. The ethanol extract obtained from fruiting bodies from T. versicolor blocked the proliferation in vitro of human breast adenocarcinoma (MCF-7) and human hepatocellular carcinoma (HepG2) cell lines (Janjušević et al., 2018). Similarly, the ethanol extracts of basidiocarp and mycelium from T. gibbosa, T. hirsuta, and T. versicolor revealed in vitro cytotoxic activity against human cervix adenocarcinoma (HeLa), human colon carcinoma (LS174), and human lung adenocarcinoma (A549) cell lines (Knežević et al., 2018). Results observed in ethanol extracts could happen via the cell cycle arrest as previously stated (Harhaji et al., 2008; Hsieh et al., 2002).
Likewise, the aqueous extracts of the fruiting bodies from C. versicolor suppress in vitro 4T1 cell migration and invasion; moreover, these extracts decreased in vivo tumor weight and lung metastasis in BALB/c mice bearing orthotopic 4T1 tumors (Luo et al., 2014). The aqueous extracts of mycelial biomass from T. versicolor and other mushrooms exhibited in vitro cytotoxic effects against human solid tumor cell lines such as A-549 and SW1573 (lung), HBL-100 and T-47D (breast), HeLa (cervix), and WiDr (colon) (Shnyreva et al., 2018). The grouping of aqueous extracts and chemotherapeutic agents (Roca-Lema et al., 2019) or metronome zoledronic acid (mZOL) (Ko et al., 2017) has also been described to increase the biological activity thereof. For example, the mixture of polysaccharide-rich aqueous extracts from T. versicolor and G. frondosa with 5-fluorouracil improved the in vitro cytotoxic effects in LoVo and HT-29 human colon cancer cells (Roca-Lema et al., 2019); the mixing of the aqueous extract from T. versicolor with mZOL avoided in vivo breast cancer propagation, metastasis, and bone destruction (Ko et al., 2017).
Furthermore, a fraction of polysaccharide isolated from the liquid culture of T. versicolor (Tramesan) exhibited in vitro antiproliferative effects in cell lines of murine melanoma B16-F10 (Scarpari et al., 2017), human myeloid (OCI-AML3), and lymphoid (Jurkat) (Ricciardi et al., 2017). This antiproliferative effect of Tramesan is associated with cell cycle arrest and apoptosis induction, although it has also been described that the effect of numerous fungal polysaccharides is associated with oxidative stress (Queiroz et al., 2015). In addition, cell cycle arrest has been assumed to occur by the inhibition of cyclin-dependent kinases and activation of cell cycle checkpoints, which lead to cell death (Khan et al., 2019). Also, in vitro antitumor activity of an intracellular protein-polysaccharide (Wang et al., 2017a) and extracellular polysaccharide (Wang et al., 2017b) obtained from T. versicolor against HeLa cells was estimated. The results showed that the growth inhibitory effect on HeLa cells occurs via cell cycle arrest with cell accumulation in S phase and an increase in apoptotic cells (Wang et al., 2017a). On the other hand, it was shown that tetralin lignans isolated from T. hirsuta displayed in vitro cytotoxic effects in human malignant glioma cells (U87)(Puri et al., 2006).
Moreover, the polysaccharides isolated from T. lactinea (Berk.) Pat exhibited in vitro antitumor activity on HepG-2 and normal hepatocyte L-02 cells, which was evidenced with the decreased cell proliferation and the increased leakage of cytoplasmic lactate dehydrogenase and the number of apoptotic cells (He et al., 2018). Also, it was shown that the PSK isolated from T. versicolor inhibited cell proliferation by cell cycle arrest and induction of apoptosis in the human pancreatic cancer cells BxPC-3, PANC-1, MIAPaCa-2, and AsPC-1 (Rosendahl et al., 2012).
Furthermore, the polysaccharides obtained from the fruiting bodies of T. robiniophila showed the ability to reduce in vitro cell proliferation in human osteosarcoma U-2 OS cells (Zhao et al., 2015a) and human osteosarcoma xenograft tumor growth in vivo (Zhao et al., 2015b). These polysaccharides induced apoptosis in tumor tissues and U-2 OS cells through a mitochondria-dependent pathway, as demonstrated by the increase in Bax/Bcl-2 ratio, activation of caspase-9 and caspase-3, and cleavage of poly(ADP-ribose)polymerase (PARP). The results indicate that the polysaccharides from T. robiniophila could be used as a possible chemotherapeutic agent athwart human osteosarcoma (Zhao et al., 2015a, 2015b). These two studies have shown enough evidence of the anticancer potential in isolated compounds from mushrooms of the genus Trametes to treat human osteosarcoma. Finally, the analysis of this systematic review showed an invaluable potential of extracts and isolated compounds from the genus Trametes as anticancer agents.
Lastly, mushroom β-glucans contain linear β-(1ã3)-linked backbones with β-(1ã6)-linked side chains of varying length and distribution. Some structural variations include 1ã4 linkages, α-glucan moieties, protein complexes, and sugar type. Mushroom β-glucans present a great variety of biological activities, highlighting their anticancer and immunomodulatory activity. These properties could be associated with their ability to induce biological responses by binding to membrane receptors. β-glucans can induce the immune system since they are not synthesized by humans and therefore they are recognized as strange agents (Phan et al., 2018).
CONCLUSION
The present systematic review has examined the current evidence on the anticancer activity of chemical compounds from mushrooms of the genus Trametes in human osteosarcoma. Finally, 15 studies were included, in which 6 of them assessed extracts, 8 studies evaluated polysaccharides, and 1 study estimated tetralin lignans of different species of the genus Trametes. The results and analysis of the articles involved in this review have provided enough indication of the anticancer potential of isolated compounds from different species of the genus Trametes. However, studies relating to the anticancer potential of bioactive mushrooms compounds in human osteosarcoma are incipient yet. These findings leave an open gap to continue with studies that help to address this health problem as well as understand the mechanisms by which these natural products have beneficial effects on the treatment of different types of cancer.
ACKNOWLEDGMENTS
Muñoz-Castiblanco T. acknowledges the doctoral fellowship granted by Colciencias (Programa de Becas de Excelencia Doctoral del Bicentenario, 2019, Primera Corte). This work was partially supported by CODI, University of Antioquia (Project no. 2019-25210).
CONFLICT OF INTEREST
The authors declare that they have no conflicts of interest.
FUNDING
None.
REFERENCES
Amirullah NA, Zainal Abidin N, Abdullah N. The potential applications of mushrooms against some facets of atherosclerosis: a review. Food Res Int, 2018; 105:517–36. CrossRef
Bao X, Yuan H, Wang C, Liu J, Lan M. Antitumor and immunomodulatory activities of a polysaccharide from Artemisia argyi. Carbohydr Polym, 2013; 98(1):1236–43. CrossRef
Blagodatski A, Yatsunskaya M, Mikhailova V, Tiasto V, Kagansky Al, Katanaev V. Medicinal mushrooms as an attractive new source of natural compounds for future cancer therapy. Oncotarget, 2018; 9(49):29259–74. CrossRef
Chen D, Zhao Z, Huang Z, Chen DC, ZhuXX, Wang YZ, Yan YW, Tang S, Madhavan S, Ni W, Huang ZP, Li W, Ji W, Shen H, Lin S, Jiang YZ. Super enhancer inhibitors suppress MYC driven transcriptional amplification and tumor progression in osteosarcoma. Bone Res, 2018a; 6(1):1–7. CrossRef
Chen Y, Wang S, Geng B, Yi Z. Pelargonidin induces antitumor effects in human osteosarcoma cells via autophagy induction, loss of mitochondrial membrane potential, G2/M cell cycle arrest and downregulation of PI3K/AKT signalling pathway. J BUON, 2018b; 23(3):735–40.
Ferrari S, Palmerini E. Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma. Curr Opin Oncol, 2007; 19(4):341–6. CrossRef
Fritz H, Fernandes R, Seely D, Cooley K, Ishii M, Kennedy DA, Fritz H, Fergusson D. Polysaccharide K and Coriolus versicolor extracts for lung cancer. Integr Cancer Ther, 2015; 14(3):201–11. CrossRef
Harhaji L, Mijatović S, Maksimović-Ivanić D, Stojanović I, MomÄilović M, Maksimović V, Tufegdžić S, Marjanović Ž, Mostarica-Stojković M, VuÄinić Ž, Stošić-GrujiÄić S. Anti-tumor effect of Coriolus versicolor methanol extract against mouse B16 melanoma cells: in vitro and in vivo study. Food Chem Toxicol, 2008; 46(5):1825–33. CrossRef
He N, Tian L, Zhai X, Zhang X, Zhao Y. Composition characterization, antioxidant capacities and anti-proliferative effects of the polysaccharides isolated from Trametes lactinea (Berk.) Pat Int J Biol Macromol, 2018; 115:114–23. CrossRef
Hsieh TC, Kunicki J, Darzynkiewicz Z, Wu JM. Effects of extracts of Coriolus versicolor (I’m-YunityTM) on cell-cycle progression and expression of interleukins-1B, -6, and -8 in promyelocytic HL-60 leukemic cells and mitogenically stimulated and nonstimulated human lymphocytes. J Altern Complement Med, 2002; 8:591–602. CrossRef
Janjušević L, Pejin B, Kaišarević S, Gorjanović S, Pastor F, Tešanović K, Karaman M. Trametes versicolor ethanol extract, a promising candidate for health–promoting food supplement. Nat Prod Res, 2018; 32(8): 963–7. CrossRef
Jiang J, Meng FY, He Z, Ning YL, Li XH, Song H, Wang J, Zhou R. Sulfated modification of longan polysaccharide and its immunomodulatory and antitumor activity in vitro. Int J Biol Macromol, 2014; 67:323–9. CrossRef
Khan T, Date A, Chawda H, Patel K. Polysaccharides as potential anticancer agents—A review of their progress. Carbohydr Polym, 2019; 210:412–28. CrossRef
Kiyama R. DNA microarray-based screening and characterization of traditional Chinese medicine. Microarrays, 2017; 6(1):4. CrossRef
Knežević A, Stajić M, Sofrenić I, Stanojković T, Milovanović I, Tešević V, Vukojević J. Antioxidative, antifungal, cytotoxic and antineurodegenerative activity of selected Trametes species from Serbia. PLoS One, 2018; 13(8):1–18. CrossRef
Ko CH, Yue GGL, Gao S, Luo KW, Siu WS, Shum WT, Shiu HT, Lee JKM, Li G, Leung PC, Evdokiou A, Lau CBS. Evaluation of the combined use of metronomic zoledronic acid and Coriolus versicolor in intratibial breast cancer mouse model. J Ethnopharmacol, 2017; 204:77–85. CrossRef
Li C, Wu X, Zhang H, Yang G, Hao M, Sheng S, Sun Y, Long J, Hu C, Sun X, Li L, Zheng J. A Huaier polysaccharide inhibits hepatocellular carcinoma growth and metastasis. Tumour Biol, 2015; 36(3):1739–45. CrossRef
Luo KW, Yue GGL, Ko CH, Lee JKM, Gao S, Li LF, Li G, Fung KP, Leung PC, Lau CBS. In vivo and in vitro anti-tumor and anti-metastasis effects of Coriolus versicolor aqueous extract on mouse mammary 4T1 carcinoma. Phytomedicine, 2014; 21(8):1078–87. CrossRef
Phan CW, Tan EYY, Sabaratnam V. Bioactive molecules in edible and medicinal mushrooms for human wellness. In: Mérillon JM., Ramawat K. (eds.). Bioactive molecules in food. Reference series in phytochemistry, Springer, Cham, Switzerland, 2018. CrossRef
Pucci B, Kasten M, Giordano A. Cell cycle and apoptosis. Cell Prolif, 2003; 36(3):165–75. CrossRef
Puri SC, Nazir A, Chawla R, Arora R, Riyaz-ul-Hasan S, Amna T, Ahmed B, Verma V, Singh S, Sagar R, Sharma A, Kumar R, Sharma RK, Qazi GN. The endophytic fungus Trametes hirsuta as a novel alternative source of podophyllotoxin and related aryl tetralin lignans. J Biotechnol, 2006; 122(4):494–510. CrossRef
Queiroz EAIF, Fortes ZB, Da Cunha MAA, Barbosa AM, Khaper N, Dekker RFH. Antiproliferative and pro-apoptotic effects of three fungal exocellular β-glucans in MCF-7 breast cancer cells is mediated by oxidative stress, AMP-activated protein kinase (AMPK) and the Forkhead transcription factor, FOXO3a. Int J Biochem Cell Biol, 2015; 67:14–24. CrossRef
Ren J, Zheng C, Feng G, Liang H, Xia X, Fang J, Duan X, Zhao H. Inhibitory effect of extract of fungi of Huaier on hepatocellular carcinoma cells. J Huazhong Univ Sci Technol, 2009; 29(2):198–201. CrossRef
Ricciardi MR, Licchetta R, Mirabilii S, Scarpari M, Parroni A, Fabbri AA, Cescutti P, Reverberi M, Fanelli C, Tafuri A. Preclinical antileukemia activity of Tramesan: a newly identified bioactive fungal metabolite. Oxid Med Cell Longev, 2017; 2017:5061639. CrossRef
Roca-Lema D, Martinez-Iglesias O, Fernández de Ana Portela C, Rodríguez-Blanco A, Valladares-Ayerbes M, Díaz-Díaz A, Casas-Pais A, Prego C, Figueroa A. In vitro anti-proliferative and anti-invasive effect of polysaccharide-rich extracts from Trametes Versicolor and Grifola frondosa in colon cancer cells. Int J Med Sci, 2019; 16(2):231–40. CrossRef
Rosendahl AH, Sun C, Wu D, Andersson R. Polysaccharide-K (PSK) increases p21WAF/Cip1 and promotes apoptosis in pancreatic cancer cells. Pancreatology, 2012; 12(6):467–74. CrossRef
Scarpari M, Reverberi M, Parroni A, Scala V, Fanelli C, Pietricola C, Zjalic S, Maresca V, Tafuri A, Ricciardi MR, Licchetta R, Mirabilii S, Sveronis A, Cescutti P, Rizzo R. Tramesan, a novel polysaccharide from Trametes versicolor. Structural characterization and biological effects. PLoS One, 2017; 12(8):1–22. CrossRef
Shnyreva AV, Shnyreva AA, Espinoza C, Padrón JM, Trigos Á. Antiproliferative activity and cytotoxicity of some medicinal wood-destroying mushrooms from Russia. Int J Med Mushrooms, 2018; 20(1):1–11. CrossRef
Suárez A, Gómez L, Soto D, Soto C, Gamboa Ó, Escandón S, Terselich G. Resultados del tratamiento de osteosarcoma convencional de alto grado en niños y adolescentes: análisis de supervivencia de una cohorte tratada sin metotrexato. Rev Colomb de Cancerol, 2017; 21(2):86–94. CrossRef
Sun Y, Sun T, Wang F, Zhang J, Li C, Chen X, Li Q, Sun S. A polysaccharide from the fungi of Huaier exhibits anti-tumor potential and immunomodulatory effects. Carbohydr Polym, 2013; 92(1):577–82. CrossRef
Tian Y, Zhao Y, Zeng H, Zhang Y, Zheng B. Structural characterization of a novel neutral polysaccharide from Lentinus giganteus and its antitumor activity through inducing apoptosis. Carbohydr Polym, 2016; 154:231–40. CrossRef
Wang KF, Sui K, Guo C, Liu CZ. Improved production and antitumor activity of intracellular protein-polysaccharide from Trametes versicolor by the quorum sensing molecule-tyrosol. J Funct Foods, 2017a; 37:90–6. CrossRef
Wang KF, Sui KY, Guo C, Liu CZ. Quorum sensing molecule-farnesol increased the production and biological activities of extracellular polysaccharide from Trametes versicolor. Int J Biol Macromol, 2017b; 104:377–83. CrossRef
Wasser SP. Current findings, future trends, and unsolved problems in studies of medicinal mushrooms. Appl Microbiol Biotechnol, 2011; 89(5):1323–32. CrossRef
Zhao X, Ma S, Liu N, Liu J, Wang W. A polysaccharide from Trametes robiniophila Murrill induces apoptosis through intrinsic mitochondrial pathway in human osteosarcoma (U-2 OS) cells. Tumour Biol, 2015a; 36(7):5255–63. CrossRef
Zhao X, Ma S, Liu N, Liu J, Wang W. A polysaccharide from Trametes robiniophila inhibits human osteosarcoma xenograft tumor growth in vivo. Carbohydr Polym, 2015b; 124:157–63. CrossRef